Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $527.6600 (0.11%) ($527.6600 - $527.6600) on Tue. Jun. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.47% (three month average) | RSI | 74 | Latest Price | $527.6600(0.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.8% a day on average for past five trading days. | Weekly Trend | REGN advances 2.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) DIA(36%) SPLV(36%) IVW(35%) | Factors Impacting REGN price | REGN will decline at least -0.735% in a week (0% probabilities). VIXM(-21%) TBT(-7%) UUP(-6%) VXX(-5%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.735% (StdDev 1.47%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $526.97(0.13%) | 10 Day Moving Average | $518.44(1.78%) | 20 Day Moving Average | $511.4(3.18%) | To recent high | -0.8% | To recent low | 14.1% | Market Cap | $55.947b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |